INFECTION IMMUNITY, Aug. 2008, p. 3679â€“3689                                                                                 Vol. 76,  8
0019-9567/08/$08.00â«¹0 doi:10.1128/IAI.01581-07
Copyright Â© 2008, American Society Microbiology. Rights Reserved.



       Shiga Toxin 2 Causes Apoptosis Human Brain Microvascular
             Endothelial Cells C/EBP Homologous ProteinäŒ¤
      Jun Fujii,1* Katie Wood,2 Fumiko Matsuda,1 Benedito  Carneiro-Filho,3 Keilo H. Schlegel,2
           Takashi Yutsudo,4 Beth Binnington-Boyd,5 Clifford  Lingwood,5 Fumiko Obata,2
                          Kwang S. Kim,6 Shin-ichi Yoshida,1 Tom Obrig2
 Department Bacteriology, Graduate School Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan1; Department   Internal Medicine/Nephrology2 Center Global Health,3 Department Medicine, University Virginia, Charlottesville,
   Virginia 22908; Discovery Research Laboratory, Shionogi & , , 2-5-1, Mishima Settsu City, Osaka 566-0022, Japan4;
        Molecular Structure Function Research Institute, Hospital Sick Children, 555 University Avenue, Toronto,
              Ontario M5G 1X8, Canada5; Division Pediatric Infectious Diseases, Johns Hopkins University School                                            Medicine, Baltimore, Maryland 212876
                       Received 30 November 2007/Returned modification 8 January 2008/Accepted 28 2008

            Shiga toxin 1 (Stx1) Stx2 produced Escherichia coli O157 known cytotoxic Vero HeLa
         cells inhibiting protein synthesis inducing apoptosis. present study, demonstrated          10 ng/ml Stx2 induced DNA fragmentation human brain microvascular endothelial cells (HBMEC),          cleavage activation caspase-3, -6, -8, -9. microarray approach used search apoptotic potential
         signals response Stx2 revealed Stx2 treatment induced marked upregulation C/EBP homologous
         protein (CHOP)/growth arrest DNA damage-inducible protein 153 (GADD153). Increased CHOP expres-
         sion dependent enzymatically active Stx1. Knockdown CHOP mRNA reduced activation          caspase-3 prevented apoptotic cell death. results suggest Stx2-induced apoptosis mediated          CHOP HBMEC involves activation intrinsic extrinsic pathways apoptosis.


   1996, outbreaks Shiga toxin (Stx)-producing Esche-                rect evidence association Gb3 death domain.
richia coli (STEC) infection occurred Japan. Sakai City,             Nonetheless, Stx-induced apoptosis reported cell
Japan, approximately 8,000 people diagnosed STEC                 types Vero cells (14), human renal proximal tubular
infection developed hemolytic-uremic syndrome                 epithelial cells (17, 18), human renal cortical epithelial cells
central nervous (CNS) complications (12, 28). CNS                   (16), lung epithelial cells (42), astrocytoma cells (1). dysfunction important predictive factor hemolytic-               demonstrated Gb3 upregulated TNF-â?£
uremic syndrome mortality children (37, 38, 43).                 interleukin-1â?¤  1â?¤) (24).
1994, established mouse model STEC-induced CNS                        Caspase activation important process apoptosis.
disorder oral infection Stx2c-producing E. coli.                 Caspases present inactive proenzymes, model showed STEC associated damage cap-                  activated proteolytic cleavage specific aspartic acid
illary endothelial cells nerve fibers brain cortex          sites. Representing extrinsic pathway apoptosis,
spinal cord (10). reported Stx2-injected rabbits              caspase-8 activated response extracellular apoptosis-
developed brain edema, indicated deterioration                inducing ligands complex receptors cytoplas-
blood-brain barrier dysfunction brain microvas-             mic death domain proteins (2). intrinsic pathway cular endothelial cells (9).                                               apoptosis, caspase-9 activated response release
   Stx family toxins, including Stx1 Stx2, comprise             cytochrome c mitochondria (23) caspase-9 1A 5B subunit proteins (32). subunit N-                   activated complexed extramitochondrial cyto-
glycosidase activity removes adenine 4324 28S RNA               chrome c, dATP, apoptotic protease-activating fac- 60S ribosomal subunit (6), rendering ribosomes inactive            tor (Apaf-1) (20). known apoptosis P3HR1 cells
protein synthesis (33). B subunit binds  high affinity)          induced anti-CD77 monoclonal antibody caspase glycosphingolipid globotriaosyl ceramide Gb3 (CD77),                independent involves intrinsic pathway (41). present specific host/mammalian cells (21, 22).                reported Stx1- Stx2-mediated apoptosis CD77 antigen marker B-cell Burkittâ€™s lymphoma                HEp-2 cells associated intrinsic pathway (15). (31, 44). Stx-mediated apoptosis Burkittâ€™s lymphoma                 reported Stx1 induction apoptosis HeLa cells
utilize extrinsic pathway Fas- tumor necrosis factor
                                                                           requires caspase-6, -8, -9 4 h, followed acti-
alpha (TNF-â?£)-mediated apoptosis.  di-
                                                                           vation caspase-3, leads fragmentation nuclear
                                                                           DNA (11).  mechanism initiation                                                                            apoptotic pathway induced Stxs unknown.
   * Corresponding author. Mailing address: Department Bacte-              endoplasmic reticulum (ER) stress response signal-
riology, Graduate School Medical Sciences, Kyushu University,
Fukuoka, 812-8582, Japan. Phone: 81-92-642-6130. Fax: 81-92-642-
                                                                           ing mechanism impairment unfolded misfolded
6129. E-mail: junfujii@bact.med.kyushu-u.ac.jp.                            proteins ER induces activation caspase-12    äŒ¤
     Published ahead print 9 June 2008.                              c-Jun NH2-terminal kinase induces C/EBP homolo-

                                                                    3679
 3680       FUJII ET AL.                                                                                                                              INFECT. IMMUN.


gous protein (CHOP) (49). mice, caspase-12 appears                          plates concentration 0.1 1,000 ng/ml. Eighteen hours later,
localized ER activated response stimuli,                    cytotoxicity measured neutral red assay.
                                                                                        Detection Gb3 HBMEC TLC/Stx1 overlay assay. layer chroma- ER stress inducer tunicamycin, releases ER Ca2â«¹                            tography (TLC) Stx1 overlay assay carried previously described
stores, leads apoptosis. Expression CHOP reg-                         (46). Duplicate TLC plates prepared loading 1, 0.5, 0.25 nmol ulated transcriptional level ER stress, essentially                  glycolipid standard mixture consisting glucosylceramide, lactosylceramide, RNA-dependent protein kinase-like endoplasmic reticu-                            Gb3 (Matreya, , PA), extracts HBMEC, RPTEC, THP-1
                                                                                     cells (106 cells). plates exposed ascending solvent lum kinase (PERK)/eukaryotic initiation factor 2â?£ (eIF-2â?£)
                                                                                     chloroform-methanol- water (60:36:8) allowed air dry 30 min fume
signaling pathway (35). Ergonul et al. showed combi-                        hood. plate used Gb3 detection Stx1 overlay assay follows.
nation TNF-â?£ Stx1 caused apoptosis phosphatidyl-                         plate immersed 0.6  gelatin warm water, incubated gentle
serine (PS) exposure DNA fragmentation human brain                            shaking overnight 37Â°C, washed TBS (50 mM Tris-HCl, 150 mM NaCl,
                                                                                     pH 7.4), incubated purified Stx1 (0.1 â?®g/ml TBS), washed twice TBS,
microvascular endothelial cells (HBMEC) (7).
                                                                                     reacted monoclonal anti-Stx1 PH1 (1 â?®g/ml TBS), reacted    present report, HBMEC isolated 4- 7-year-                          goat anti-mouse immunoglobulin Gâ€“horseradish peroxidase conjugate (diluted
old children constitutively sensitive Stx2. Using cell                  1/2,000 TBS).
line, report Stx2 causes apoptosis CHOP-                             Flow cytometric analysis determination apoptotic HBMEC. 0, 6, 12,
mediated signaling pathway process im-                          18, 24 h addition Stx2 (10 ng/ml), cells harvested                                                                                      centrifugation 200 â«» g 10 min, washed twice phosphate-buffered saline
portant pathophysiological response humans Stx2                         (PBS), resuspended binding buffer. extracellularly exposed PS detec-
bacterial toxin.                                                                     tion, annexin V-EGFP (4 mg/ml) employed, detection nuclear
                                                                                     membrane disruption, propidium iodide (PI; 2.5 mg/ml) utilized. 
                                                                                     agents added cells, cells incubated room temperature                         MATERIALS METHODS                                        dark. addition 500 â?®l binding buffer, cells analyzed                                                                                      FACScan cytometer (Becton Dickinson, San Jose, CA) equipped 488-nm
   Purification Stx1 Stx2. Stx1 purified Stx1-hyperproducing E.
                                                                                     argon laser (FL1) 568-nm argon-krypton laser (FL2). detection coli described previously (47), Stx2 immunoaffinity purified                                                                                      apoptotic marker, reduction mitochondrial membrane potential,
clinical isolate STEC (26). toxins determined free detect-
                                                                                     JC-1 dye used flow cytometry. Cells (5 â«» 105) resuspended 1 ml
able lipopolysaccharide Toxicolor test (Seikagaku Kogyo , Tokyo,
                                                                                     medium containing 100 â?®g JC-1 incubated 37Â°C 10 min. cells Japan), sodium dodecyl sufate-polyacrylamide gel electrophoresis, silver
                                                                                     washed twice cold PBS, samples analyzed FACScan. JC-1
staining. nontoxic Stx1 mutant (Stx1R170L) purified described previously
                                                                                     fluorescence analyzed FL1 FL2 channels detection dye
(34). 50  cytotoxic dose (CD50) Stx1R170L protein 9,000-fold higher
                                                                                     monomer J-aggregate forms, respectively. native Stx1, assessed basis Vero cell cytotoxicity.
                                                                                        Transmission electron microscopy. Nonconfluent HBMEC grown    Cell culture. HBMEC isolated cultured previously described (40).
                                                                                     Costar culture plates treated Stx2 (10 ng/ml) 18 h. cells HBMEC maintained RPMI 1640 containing 10  fetal bovine serum                 fixed processed electron microscopy previously described (29). Briefly,
(FBS), 10  NuSerum, 2 mM L-glutamine, 1 mM sodium pyruvate, 1 U/ml                   cells fixed 2  glutaraldehyde 1  OsO4, dehydrated
minimal essential medium nonessential amino acids, 1 U/ml minimal es-           ethanol, embedded Epon. Ultrathin sections stained uranyl
sential medium vitamins, 5 U/ml heparin incubated 37Â°C 5        acetate followed lead citrate examined electron microscopy JEM
CO2 atmosphere. Primary human renal proximal tubular epithelial cells                2000EX instrument (JEOL, , Tokyo, Japan).
(RPTEC) purchased Clonetics (Walkersville, MD). RPTEC                    DNA fragmentation analysis Stx2-treated HBMEC presence maintained renal epithelial cell growth medium supplemented human            caspase inhibitors. HBMEC pretreated caspase inhibitors (20 â?®M) epidermal growth factor, hydrocortisone, epinephrine, insulin, tri-iodothyronine,    30 min 37Â°C, including general caspase inhibitor inhibitors caspase-1,
transferrin, GA-1000, FBS. Undifferentiated human leukemia THP-1 cells           caspase-2, caspase-3, caspase-6, caspase-8, caspase-9, Stx2 (10 ng/ml) purchased American Type Culture Collection (Manassas, VA)              treatment. cells harvested centrifugation 200 â«» g 10 min. maintained RPMI 1640 (Gibco BRL, Grand Island, NY) supplemented               DNA extracted according DNA extraction kit instructions (Sepa Gene, 10  FBS.                                                                        Sankou-jyunyaku  , Tokyo, Japan). Briefly, cell pellets lysed    Reagents antibodies. General caspase inhibitor Val-Ala-Asp-fluoro-          0.3 ml hypotonic lysing buffer (10 mM Tris, 10 mM EDTA) containing 0.5 
methyl ketone (fmk), caspase-1 inhibitor Tyr-Val-Ala-Asp-fmk, caspase-2 inhib-     Triton X-100, lysates centrifuged 13,000 â«» g 10 min separate
itor Val-Asp-Val-Ala-Asp-fmk, caspase-3 inhibitor Asp-Glu-Val-Asp-fmk,           fragmented intact chromatin. supernatant containing fragmented
caspase-6 inhibitor Val-Glu-Ile-Asp-fmk, caspase-8 inhibitor Ile-Glu-Thr-        DNA transferred new microcentrifuge tube, pellet (intact
Asp-fmk, caspase-9 inhibitor Leu-Glu Asp-fmk purchased           DNA) supernatant (fragmented DNA) treated 1 N perchloric acid
Enzyme Products (Livermore, CA). Etoposide purchased Bi-             4Â°C 30 min. precipitates sedimented 13,000 â«» g 20 min.
omol Research Laboratory  (Plymouth Meeting, PA). Rabbit anti-human              DNA precipitates hydrolyzed heating 70Â°C 10 min 0.15 ml
cytochrome c antibody purchased Research Diagnostic,  (Flanders,        1 N perchloric acid. samples transferred 96 enzyme-linked
NJ). Polyclonal antibodies active caspase-3, -6, -8, -9, Bid        immunosorbent assay plate, A570 dye measured, purchased Cell Signaling Technology (Beverly, MA). Anti-â?¤-actin antibody        DNA quantified using modified Burton method (5). tunicamycin purchased Sigma Chemical  (St. Louis, MO).                 Western blot analysis Stx2-treated HBMEC. HBMEC treated Monoclonal anti-FLICE-like inhibitory protein (FLIP) antibody (NF6) pur-         Stx2 (10 ng/ml) 0, 2, 4, 7, 10 h. Cells lysed, proteins chased Alexis Biochemicals (San Diego, CA). annexin V-enhanced              analyzed Western blotting. caspases, c-FLIPL, Bid green fluorescent protein (EGFP) kit purchased BD Biosciences Clon-         internal control â?¤-actin detected immunoblotting previously described
tech (Palo Alto, CA). 5,5â¬˜,6,6â¬˜-Tetrachloro-1,1â¬˜,3,3â¬˜-tetraethylbenzimidazolyl-      Bitko Barik (4). Cytosolic cytochrome c quantified described carbocyanine iodide (JC-1) obtained Molecular Probes (Eugene, .          Heibein et al. (13). Immunodetection carried using ECL detection
Recombinant active caspase-6 (rCasp-6) purchased Biomol Research            (Amersham Pharmacia Biotech, United Kingdom). Protein expression
Laboratory  (Plymouth Meeting, PA).                                              quantified LAS1000 Plus luminescent image analyzer (Fujifilm, Tokyo,
   Cytotoxicity assay. time response experiments, HBMEC dispensed           Japan). 96 culture plates density 10,000 cells (70 80             Cell-free assay using rCasp-6. Cell extracts freshly prepared confluent cells). Cells maintained medium served 100  viability      HBMEC described previously (30) modifications. Briefly, non-
control. plates incubated 4 h, Stx2 (10 ng/ml) added,      treated cells harvested centrifugation 1,600 â«» g 5 min 4Â°C. cells incubated 0, 6, 12, 18, 24 h. Surviving cells        cell pellet washed twice ice-cold PBS (0.1 M phosphate buffer 0.15
measured neutral red assay (25). obtain toxin dose-response survival         M NaCl, pH 7.4), followed single wash ice-cold caspase buffer (20 mM
curves, HBMEC dispensed 96 culture plates density 5,000       PIPES, 100 mM NaCl, 10 mM dithiothreitol, 1 mM EDTA, 0.1  CHAPS
cells  plates incubated 4 h (nonconfluent cells) 24 h   {3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate}, 250 mM su-
(confluent cells), medium replaced fresh medium. Stx2 added         crose, pH 7.2). centrifugation, cells resuspended volumes
 VOL. 76, 2008                                                                                Stx2 CAUSES APOPTOSIS HBMEC CHOP                                   3681




   FIG. 1. HBMEC sensitive Stxs.   Cytotoxic effects Stx1 Stx2 (10 ng/ml) nonconfluent HBMEC assessed neutral red assay 6, 12, 18, 24 h incubation, viability displayed 0 h taken 100 . (B) Confluent nonconfluent HBMEC prepared described Materials Methods exposed different concentrations Stx2. 18 h, cytotoxicity measured neutral red assay. Cells
maintained medium served 100  viability control. error bars deviations independent experiments.


 ice-cold complete caspase buffer supplemented protease inhibitors (100              CHOP mRNA knockdown experiment using siRNA. different sequences
â?®M phenylmethylsulfonyl fluoride, 10 â?®g/ml leupeptin, 2 â?®g/ml aprotinin)             small interfering RNA (siRNA) CHOP/DDIT3, validated Stealth
transferred 2-ml Dounce homogenizer. cells disrupted 50               RNA interference (RNAi) DuoPak (Duplex1, siRNA-CHOP.1; Duplex2,
strokes B-type pestle (Fisher Scientific , Nepean,  Canada). Cell            siRNA-CHOP.2), provided Invitrogen (Carlsbad, CA). Stealth RNAi-
disruption (â¬Ž95 ) confirmed examination aliquots trypan blue-             negative control duplexes (NC-siRNA; Invitrogen) GC content similar stained suspension light microscope. nuclei removed cen-             duplex siRNA used negative controls. Duplex siRNAs trifugation 20,000 â«» g 10 min 4Â°C. rCasp-6 added cell extracts,     transfected HBMEC using Lipofectamine RNAiMAX (20 pmol/ml) accord- extracts incubated 0, 15, 30, 45, 60 min. fractions          ing manufacturerâ€™s instructions 24 h prior adding Stx2 (10 ng/ml).
stored â«º80Â°C use. ability rCasp-6 cleave caspase-8                Knockdown endogenous CHOP mRNA level confirmed qRT-PCR
caspase-3 cell extracts analyzed immunoblotting described         analysis described  transfected cells incubated Stx2
   DNA microarray analysis Stx2-treated HBMEC. 0, 6, 10, 19 h            (10 ng/ml) 18 h, immunoblotting carried anti-caspase-3. 
addition Stx2 (10 ng/ml), HBMEC harvested described previously         siRNA-transfected cells dispensed 96 culture plates total RNA extracted using RNAgents total RNA isolation (Promega,          density 10,000 cells incubated different concentrations
Tokyo, Japan). Microarray experiments using human genome oligonucle-           Stx2 (0.1 1,000 ng/ml) 18 h. neutral red cytotoxicity assay otide microarray (44K oligonucleotide DNA microarray; Agilent Technologies,           performed address influence CHOP survival following exposure kyo, Japan) performed according manufacturerâ€™s protocol. total           cells Stx2.
RNA samples used preparation Cy5- Cy3-labeled cDNA probes.              Statistical analysis. Basically, assays performed triplicate nontreated sample (0 h) used control. hybridized washed             independent experiments. Statistical analysis involved analysis variance, material glass slide scanned DNA microarray scanner (model            followed unpaired Studentâ€™s t test Bonferroni test SPSS
G2505A; Agilent Technologies). Feature Extraction Image Analysis soft-           15.0J. Statistical differences considered significant P â¬?0.05.
ware (Agilent Technologies) used locate delineate spot array     Statistical analyses microarray data performed using Feature Ex- integrate intensities, filtered normalized using   traction Image Analysis software (Agilent Technologies).
locally weighted scatterplot smoothing method. Gene clustering analysis 
formed Genespring 7, version 1.1 (Silicon Genetics). reproducibility microarray analysis assessed repetitions dye swap experiment.                                        RESULTS
mRNA expression differences control HBMEC HBMEC harvested 6, 10, 19 h compared.                                                              Cytotoxicity Stxs HBMEC. HBMEC incubated
   qRT-PCR CHOP Stx2-treated HBMEC. HBMEC treated                        Stx1 Stx2, cell viability assessed neutral Stx1, Stx2, Stx1R170L, tunicamycin, etoposide 0, 4, 7, 10, 13, 16 h.   red assay. toxin 10 ng/ml induced cell death Treatment cells antibiotic tunicamycin, prevents transfer       time-dependent manner (Fig. 1A). cell viabilities follow- oligosaccharide chain dolichol-phosphate donor specific aspar-
agine residues nascent polypeptide chain (36), leads accumulation misfolded nonglycosylated proteins ER induces ER stress. cells harvested, total RNA extracted. micrograms total RNA sample used generate cDNA using ABI high-capacity cDNA
archiving kit (Applied Biosystems, Foster City, CA). oligonucleotides forward reverse primers TaqMan probe human CHOP designed using Primer Express software (Applied Biosystems). sequences oligonucleotides follows: human CHOP (GenBank accession number
NM_004083) forward primer, 5â¬˜-CTCTGGCTTGGCTGACTGA-3â¬˜; reverse
primer, 5â¬˜-GCTCTGGGAGGTGCTTGT-3â¬˜; reporter probe, CAGAACCAGC
AGAGGTC. real-time PCRs carried following manufac-
turerâ€™s protocol. Expression mRNA CHOP measured quantitative                 FIG. 2. Detection Stx1 receptor glycolipid (Gb3) RPTEC,
reverse transcription-PCR (qRT-PCR) using TaqMan gene expression assays                  HBMEC, THP-1 cells Stx1 overlay assay. RPTEC, HBMEC, ABI Prism 7000 sequence detection (Applied Biosystems, Foster            THP-1 cell neutral glycolipids prepared 106 cells City, CA). plate, endogenous control gene (â?¤-actin gene)                  separated TLC. relative Gb3 concentrations estimated template-negative controls run duplicate. CHOP mRNA expression              1.6 nmol (RPTEC), 0.4 nmol (HBMEC), 1.4 nmol (THP-1) normalized â?¤-actin mRNA.                                                        based standard Gb3.
 3682
 VOL. 76, 2008                                                                   Stx2 CAUSES APOPTOSIS HBMEC CHOP                       3683




  FIG. 3. Flow cytometric analysis apoptotic markers electron microscopic analysis.   Apoptotic necrotic cells analyzed using
annexin V PI markers. Stx2 (10 ng/ml)-exposed HBMEC harvested time points shown stained annexin V-EGFP (4
mg/ml) PI (2.5 mg/ml). results depicted dot plots showing FL1 (488 nm/EGFP) FL2 (568 nm/PI) channels. (B) Percentages cells undergoing early apoptosis, late apoptosis, necrosis quantitated represented bar graph. error bars deviations independent experiments. â´±, P â¬? 0.05 versus 0-h control (unpaired t test). (C) Decrease mitochondrial membrane
potential (âŒ¬â?º) induced Stx2 HBMEC detected using JC-1. results depicted dot plots FL1 (488 nm/monomer JC-1) FL2 (568 nm/aggregate JC-1) channels. intact membrane/high âŒ¬â?º-retaining population reduced-âŒ¬â?º population gated designated
gate 1 gate 2, respectively. (D) Percentages gate 1 gate 2 populations. shift gate 1 gate 2 result decrease âŒ¬â?º. error bars deviations independent experiments. â´±, P â¬? 0.05 versus 0-h value (Bonferroni t test). (E) Typical
chromatin condensations (arrows) observed apoptotic cell 18 h incubation Stx2 (10 ng/ml). Bars, 1 â?®m.




ing Stx1 Stx2 treatment statistically different              PI positive, shown upper left quadrant Fig. time course assessed. HBMEC incubated                         3A. results Fig. 3A summarized quantified different concentrations Stx2 18 h                    percentages total cell population Fig. 3B. significant
assessed cytotoxicity, Stx2 dose response observed                increase early apoptosis observed 12, 18, 24 h confluent nonconfluent cells (Fig. 1B).                     compared control (0 h). Late apoptosis slightly
CD50 nonconfluent cells treated Stx2 1                increased time-dependent manner.  percent-
ng/ml Stx2, CD50 confluent cells                    age necrotic cells did change time course. 1,000 ng/ml Stx2.                                                      change mitochondrial membrane potential 
   Detection Gb3 Stx1 binding. Similar amounts cell-               marker apoptotic cells detectable JC-1, extracted neutral lipids RPTEC, HBMEC, THP-1                       cationic dye accumulates mitochondria. cells loaded TLC plates visualized Stx1                  mitochondrial membrane intact, dye forms aggregates
overlay assay. Gb3 expression levels HBMEC, RPTEC,                   present orange fluorescence (FL2), THP-1 cells compared standards determined                 damaged membrane lower dye concentration occurs 0.4, 1.6, 1.4 nmol/million cells, respectively (Fig. 2).                dye remains monomer appears green fluorescence
   Flow cytometric analysis exposed PS mitochon-                  (FL1).  population high membrane potential drial membrane potential. Following exposure HBMEC                    indicated gate 1 population low membrane
Stx2 0, 6, 12, 18, 24 h, cells harvested stained           potential indicated gate 2. membrane potential EGFP-conjugated annexin V PS detection PI                 shown decrease shift gate 1 gate 2 (Fig. 3C). nuclear membrane disruption. Quantification cell death               percentages scatter population summarized Fig. analyzed flow cytometry, shown scatterplot                 3D. JC-1 aggregates decrease significantly 12, 18, (Fig. 3A; x axis, FL1/annexin V; y axis, FL2/PI). assay                24 h compared 0 h, following exposure Stx2 (Fig. 3D, gate
identifies apoptotic necrotic cells. Viable cells negative          1). indicates Stx2 induced loss mitochondrial annexin V PI shown lower left quadrant               membrane potential HBMEC.  corre- Fig. 3A. Cells stained positive annexin V               lation timing loss mitochondrial membrane po-
negative PI, shown lower right quadrant             tential (Fig. 3D) leakage cytochrome c mitochon-
Fig. 3A, indicative early apoptosis. Cells late apoptosis         dria cytoplasm  Fig. 4D) Stx2 exposure. annexin V PI positive shown upper                      Electron microscopic analysis. shown Fig. 3E, cells
right quadrant Fig. 3A. Necrotic cells, annexin V negative               exposed Stx2 undergo morphological changes including
 3684      FUJII ET AL.                                                                                                                 INFECT. IMMUN.




   FIG. 4. Detection DNA fragmentation elements caspase cascade induced Stx2 HBMEC.   Stx2-induced DNA ladder
formation decrease ladder caspase inhibitors HBMEC. Lane 1, control; lane 2, Stx2 (10 ng/ml)  lane 3, Stx2 general caspase inhibitor; lane 4, caspase-1 inhibitor; lane 5, caspase-2 inhibitor; lane 6, caspase-3 inhibitor; lane 7, caspase-6 inhibitor; lane 8,
caspase-8 inhibitor; lane 9, caspase-9 inhibitor. (B) DNA fragments quantified modification diphenylamine method Burton
(5) described Materials Methods. error bars deviations independent experiments. â´±, P â¬? 0.05 versus Stx2 
(C) Induction caspase cascade proteins Stx2 (10 ng/ml) HBMEC analyzed Western blotting. Detected bands FLIPL, cleaved
caspase-8, cleaved caspase-6, cleaved caspase-3 loading control, â?¤-actin, shown. Procaspase-1 changed (data shown).
(D) Bands length Bid, cytochrome c, caspase-9, loading control, â?¤-actin, shown. Note length Bid reduced 6 h Stx2 (10 ng/ml) incubation HBMEC, indicating increase active/truncated Bid (tBid). Cytochrome c release mitochondria cleavage caspase-9 occurred following Bid activation. experiment repeated twice similar results.




chromatin condensation (Fig. 3E, Stx2) periphery nucleus. cellular apoptosis accompanied cyto-
plasmic blebs (Fig. 3E, Stx2).
   Altered Stx2-induced DNA fragmentation caspase inhib-
itors. HBMEC pretreated 20 â?®M caspase inhibitors 30 min 37Â°C exposed Stx2 (10 ng/ml). Preparation DNA extracts performed 24 h Stx2 treatment.
Fragmented DNA visualized DNA ladder (Fig. 4A) quantified Burton method (Fig. 4B). general
caspase inhibitor completely blocked formation DNA
ladder (Fig. 4A, lane 3, B, Stx2 VAD-fmk), spe-
cific inhibitors caspase-1, caspase-3, caspase-6, caspase-8, caspase-9 partially blocked DNA ladder formation (Fig.
4A B). contrast, caspase-2 inhibitor did signif-
icantly decrease DNA fragmentation induced Stx2 (Fig. 4A B).
   Caspase activities apoptosis-related proteins Stx2-                   FIG. 5. Activation caspase-8 -3 exogenous rCasp-6 treated HBMEC. presence Stx2, HBMEC expression                      HBMEC lysate. Active rCasp-6 PBS control added antiapoptotic protein c-FLIPL decreased disappeared                    normal HBMEC extracts, extracts incubated 15 min, 30
                                                                              min, 45 min, 60 min. fragments cleaved fragments completely 6 h, followed cleavage activation caspase-8,              caspase-8   -3 (C) detected cell extracts containing
caspase-3, caspase-6 (Fig. 4C). known novo                  rCasp-6 immunoblotting. Addition PBS cell extracts did synthesis c-FLIPL inhibited protein synthesis inhibitors             cause cleavage caspase-8 (B) caspase-3 (D).
 VOL. 76, 2008                                                      Stx2 CAUSES APOPTOSIS HBMEC CHOP                    3685


                              TABLE 1. Changes HBMEC mRNA expression Stx2 treatmenta
                                                                                    Change mRNA expression (fold)b 
   Family accession                Producer mRNA
                                                                            6h                      10 h                     19 h

Caspase family
  NM_033292                           Caspase-1                            1.00                     1.17                    1.23*
  NM_032982                           Caspase-2                            0.98                     1.28                    0.85
  NM_004346                           Caspase-3                            1.21                     0.95                    0.61*
  NM_033306                           Caspase-4                            1.29                     0.81                    0.94
  NM_004347                           Caspase-5                            1.21                     1.04                    0.92
  NM_001226                           Caspase-6                            0.85                    12.72Å’                   1.01
  NM_033338                           Caspase-7                            0.91                     0.88                    1.09
  NM_033356                           Caspase-8                            1.07                     0.89                    0.85
  NM_001229                           Caspase-9                            1.67                     1.98                    2.63Å’*
  AF111344                            Caspase-10                           1.23                     0.75                    1.74
  NR_000035                           Caspase-12                           1.37                     0.82                    0.75
  NM_012114                           Caspase-14                           0.93                     1.12                    0.93

Bcl-2 family
  NM_000657                           Bcl-2                                1.01                     0.95                    0.96
  NM_004322                           BAD                                  0.96                     1.26                    1.02
  NM_138764                           BAX                                  0.93                     2.17Å’                   1.39
  NM_001196                           BID                                  0.90                     0.82                    0.87

Death domain related genes
 NM_003824                            FADD                                 1.09                     1.03                    0.96
 U97075                               FLIP, short form                     1.34                     1.68                    1.63
 NM_003879                            CFLAR                                1.44                     1.40                    1.06

XIAP Apaf-1
  U45880                              XIAP                                 1.15                     0.95                    1.01
  NM_017523                           XIAP-associated factor 1             2.49Å’                    1.21                    0.61
  NM_181861                           Apaf-1                               0.86                     1.03                    0.96

TRAF
 NM_005658                            TRAF1                                1.69                     1.65                    1.70
 NM_021138                            TRAF2                                0.98                     1.39                    0.90
 NM_145725                            TRAF3                                1.05                     0.70                    0.94
 NM_004295                            TRAF4                                1.08                     0.71                    1.08
 NM_004619                            TRAF5                                0.77                     1.22                    1.28
 NM_145803                            TRAF6                                1.43                     1.14                    1.08

GADD ATM
 NM_001924                            GADD45A                              4.44Å’*                   1.33                    2.83Å’*
 NM_015675                            GADD45B                              3.58Å’*                   1.21                    1.57
 NM_138293                            ATM                                  1.00                     1.24                    0.76
 NM_014330                            GADD34                               3.23Å’*                   1.36                    3.75Å’*

eIF
  NM_004681                           eIF-1AY                              1.45                     0.59                    0.72
  NM_004836                           eIF-2AK3(PERK)                       2.26Å’*                   1.39                    2.04Å’*
  NM_032025                           eIF-2A                               1.06                     0.96                    1.05
  BC013590                            eIF-2B                               1.23                     1.00                    1.34
  NM_001967                           eIF-4A2                              1.55                     1.02                    1.64

CREB
 NM_134442                            CREB1                                1.01                     0.96                    0.96
 NM_181715                            CREB2                                0.94                     1.24                    1.12*
 NM_022769                            CREB3                                0.96                     0.61                    0.95
 NM_004904                            CREB5                                9.75Å’*                   2.50Å’                   9.46Å’*

ER stress related genes
 NM_004083                            CHOP                                 4.99Å’*                   1.51                    4.40Å’*
 NM_001675                            ATF4                                 1.98*                    1.55                    2.74Å’*
 NM_005080                            XBP-1                                1.20                     1.00                    0.80
 AF188611                             BiP                                  0.77                     1.05                    0.60
 NM_016306                            HEDJ/ERdj3                           1.00                     0.98                    0.93
 NM_021158                            TRIB3                                0.87                     0.86                    0.89
                                                                                                       Continued following page
 3686      FUJII ET AL.                                                                                                                  INFECT. IMMUN.


                                                                TABLE 1â€”Continued
                                                                                                        Change mRNA expression (fold)b 
   Family accession                          Producer mRNA
                                                                                               6h                        10 h                     19 h


Myd88 TRIF
 NM_002468                                      MYD88                                         0.89                      1.21                     0.87
 NM_014261                                      TRIF                                          0.96                      1.22                     1.00

p38
  NM_000584                                     8                                         16.49Å’*                    2.58Å’                   14.08Å’*

p53
  NM_000546                                     TP53                                          1.27                      1.20                     2.56Å’
      Abbreviations: FADD, Fas-associated death domain; CFLAR, caspase-8- FADD-like apoptosis regulator; XIAP, X-linked inhibitor apoptosis protein;
TRAF, TNF receptor-associated factor; GADD, growth arrest DNA damage-inducible protein; ATM, ataxia telangiectasia mutated; CREB, cyclic AMP response
element binding protein; CHOP, C/EBP homologous protein; XBP-1, x-box-binding protein 1; HEDJ, human ER-associated DNAJ; ERdj3, endoplasmic reticulum-
localized DnaJ homologues 3; TRIF, Toll 1 receptor domain-containing adaptor inducing beta interferon.
  bÅ’
      , â¬Ž2.0-fold increase versus 0-h value; â´±, P â¬? 0.05 versus 0-h value.




including Stxs cycloheximide (8). c-FLIPL inhibits                 [growth arrest DNA damage-inducible protein 153]) gene
caspase-8 activity, decrease FLIPL enhances activation                increased significantly. GADD45A, GADD45B, eIF- caspase-8. results suggest protein synthesis inhibi-               2AK3 (PERK), CREB5, 8 genes significantly
tion Stx2 induced caspase-8 activity HBMEC (Fig. 4C),                    upregulated response Stx2 HBMEC. noted  case, identification primary initiator             GADD45A GADD45B previously associated
apoptosis established. Nonetheless, activated                     DNA arrest HCT116 cells S phase (3) 8
caspase-8 cleaves length Bid shorter truncated Bid,                  associated ribotoxic stress protein kinase c-Jun NH2-
tBid, tBid known cause mitochondrial membrane                        terminal kinase/stress-activated protein kinase (39).  rupture (48).  activation Bid, proapoptotic Bcl-2                eIF-2â?£/ATF4 (activating transcription factor 4) signaling path-
family protein, link extrinsic pathway                    way known play essential role induction intrinsic pathway apoptosis.  6 h incubation                CHOP ER stress (35). Stx2, decrease length Bid detected                   Verification microarray results. microarray results time-dependent manner, decrease resulted                     verified using qRT-PCR analyses TaqMan probe
crease tBid (Fig. 4D). data indicate Stx2 induces                  CHOP. shown Fig. 6, Stx1R170L enzymatic site
cleavage Bid caspase-8 activation. result Bid                   mutant did cause increase CHOP mRNA expression,
activation, release cytochrome c mitochondria                   native Stx1 Stx2 caused 10-fold increase CHOP
cytoplasm detected 12 h, followed                  mRNA expression compared Stx1R170L (P â¬? 0.05). Tunica-
caspase-9 cleavage (Fig. 4D). time course cytochrome c
leakage matched decreased mitochondrial membrane po-
tential detected JC-1 (Fig. 3D).
   Cell-free assay using rCasp-6. Based kinetic data immunoblotting, investigated caspase-6 directly cleave caspase-8 normal cell extract HBMEC. cell extracts exposure Stx2 collected, rCasp-6 added cell extracts. early 15 min adding rCasp-6, cleaved caspase-8 (43, 41 kDa) detected, 30 min, cleavage caspase-3 (17 kDa) detected
(Fig. 5).  caspase-6 function amplifier caspase-8â€“caspase-3-activated 
   DNA microarray data analysis. understand 
stream factors caspase activation induced Stx2, ana-
lyzed gene expression profiles HBMEC treated Stx2 6, 10, 19 h compared untreated
control HBMEC. examined expression â¬ƒ44,000
genes using human oligonucleotide microarray 44K.                       FIG. 6. Validation CHOP mRNA expression induced Stx2 genes exhibited significantly altered gene ex-                  HBMEC. HBMEC incubated Stx1 (10 ng/ml), Stx2 (10
pression Stx2-treated untreated control cells,                 ng/ml), Stx1R170L (10 ng/ml), tunicamycin (1 â?®g/ml), etoposide (100
51 apoptosis-related genes (Table 1). apoptosis                    â?®M) times indicated. CHOP mRNA expression
                                                                               analyzed qRT-PCR depicted ratio mRNA expres-
lated genes classified 12 groups, shown                sion Stx1 mRNA expression 0 h. error bars indicate Table 1.  expression ER stress-related genes                  deviations independent experiments. â´±, P â¬? 0.05 Stx1 C/EBP homologous protein (CHOP/GADD153                             Stx2 versus Stx1 R170L etoposide (unpaired t test).
 VOL. 76, 2008                                                                   Stx2 CAUSES APOPTOSIS HBMEC CHOP                       3687




   FIG. 7. CHOP knockdown HBMEC reduces caspase-3 activation increases viability induced Stx2.   HBMEC serially
transfected CHOP siRNA-CHOP.1 -CHOP.2 NC-siRNA. Endogenous CHOP mRNA depletion examined qRT-PCR
analysis. Note siRNA-CHOP.1 55  reduction CHOP transcript levels compared NC-siRNA (â´±, P â¬? 0.05,
unpaired t test). (B) Caspase-3 cleavage 18 h incubation Stx2 (10 ng/ml) decreased siRNA-CHOP.1-transfected HBMEC
compared NC-siRNA-transfected HBMEC. cleaved caspase-3 detected immunoblotting loading control â?¤-actin. (C) results additional experiments similar panel B quantified densitometry displayed percentages cleavage NC-siRNA-transfected cells (100 ). Caspase-3 cleavage statistically decreased siRNA-CHOP.1-transfected HBMEC compared NC-siRNA-transfected HBMEC (â´±, P â¬? 0.05, unpaired t test). (D) viability Stx2-treated HBMEC transfected siRNA-
CHOP.1, siRNA-CHOP.2, NC-siRNA measured neutral red assay. siRNA-CHOP.1-transfected cells significantly resistant toxin compared cell viability NC-siRNA-transfected cells (P â¬? 0.05, unpaired t test) doses Stx2 0.1 1,000 ng/ml. error bars deviations 4 wells 96 culture plates. experiment repeated times similar results.



mycin, used CHOP-inducing control, increased                      compared control cells identically transfected non-
CHOP mRNA expression, peaked 10 h incubation.                   targeting siRNA oligonucleotide (NC-siRNA) (Fig. 7A). DNA-damaging topoisomerase II inhibitor etoposide did                   Knockdown construct siRNA-CHOP.1 produced significant  induce CHOP mRNA, reported previously (27). Etopo-                   duction CHOP mRNA. results accurately reflected treatment (100 â?®M) 18 h, known induce apoptosis,                concordant reduction Stx2-induced cleavage caspase-3 resulted 29  cell death, measured neutral red assay              CHOP knockdown cells, measured immunoblotting (Fig. 7B
(data shown).                                                           C).  siRNA-CHOP.1-transfected cells resis-
   siRNA knockdown CHOP. test involvement                      tant toxin compared NC-siRNA-transfected cells (P â¬?
CHOP-mediated apoptosis induced Stx2 HBMEC,                           0.05, unpaired t test) (Fig. 7D).
CHOP knocked RNAi. HBMEC serially
transfected duplex siRNA oligonucleotides targeted                                                DISCUSSION CHOP, extent endogenous CHOP depletion examined. qRT-PCR analysis mRNA extracted                         reported previously, HBMEC likely target
siRNA-transfected cells revealed 55  (siRNA-CHOP.1)                   Stxs (9, 10);  employed HBMEC demonstrate
21  (siRNA-CHOP.2) reduction CHOP transcript levels                      direct effect Stxs cell type. Recently, Ergonul et
 3688     FUJII ET AL.                                                                                                                  INFECT. IMMUN.


al. (7) reported TNF-â?£- Stx1-induced apoptosis                                       ACKNOWLEDGMENTS
HBMEC mediated caspase-3. investigated                 thank Shinji Yamasaki (Osaka Prefecture University, Osaka,
enhanced cytotoxicity Stxs TNF-â?£ HBMEC.                 Japan) providing Stx1 mutant Stx1R170L. thank 
Neutral red assays performed described Materials            momi Gotoh (Kumamoto University School Medicine, Japan)                                                                        helpful discussion Sharon Y.  M. Villanueva (Kyushu Univer- Methods, HBMEC sensitive              sity) correcting English. thank Akemi Takade (Kyushu
Stx1 Stx2 TNF-â?£ (data shown). present              University) technical support electron microscopy.
study, investigate cell death induced HBMEC              work supported grants aid scientific research Stx2 apoptosis necrosis, focused major            U.S.-Japan Cooperative Medical Science Program
                                                                       (KH19AI0010) Ministry Health, Labor Welfare biochemical features apoptotic cells, include   ex-         Japan U.S. Public Health Service grant AI24431  T.O.).
tracellular exposure PS early stage apoptosis, (ii)
                                                                                                        REFERENCES
loss mitochondrial membrane potential, (iii) DNA fragmen-
                                                                        1. Arab, S., M. Murakami, P. Dirks, B. Boyd, S. L. Hubbard, C.  Lingwood,
tation final stage apoptosis, (iv) activation caspase       J. T. Rutka. 1998. Verotoxins inhibit growth induce apoptosis
cascade, (v) morphological changes. results indicated              human astrocytoma cells. J. Neurooncol. 40:137â€“150. death HBMEC caused Stx2 treatment              2. Ashkenazi, , V. M. Dixit. 1998. Death receptors: signaling mod-
                                                                           ulation. Science 281:1305â€“1308. apoptosis, caspase-1 inhibitor shown              3. Bhattacharjee, R. N., K. S. Park, S. Uematsu, K. Okada, K. Hoshino, K.
significantly reduce formation DNA ladder.                        Takeda, O. Takeuchi, S. Akira, T. Iida, T. Honda. 2005. Escherichia coli
                                                                           verotoxin 1 mediates apoptosis human HCT116 colon cancer cells    purpose present study determine possible            inducing overexpression GADD family genes S phase arrest.
origin Stx-induced apoptosis human endothelial cells              FEBS Lett. 579:6604â€“6610.
                                                                        4. Bitko, V., S. Barik. 1998. Persistent activation RelA respiratory
vitro. demonstrate enzymatic activity Stx1             syncytial virus involves protein kinase C, underphosphorylated ? Bâ?¤, Stx2 required induction CHOP mRNA expression                 sequestration protein phosphatase 2A viral phosphoprotein. J. Vi- HBMEC. noted CHOP activated                 rol. 72:5610â€“5618.
                                                                        5. Burton, K. 1956. study conditions mechanism diphe- Ire1, PERK, ATF6 pathways, key                     nylamine reaction colorimetric estimation deoxyribonucleic acid.
components ER stress response (45). Recently Lee et al.             Biochem. J. 62:315â€“323.
                                                                        6. Endo, Y., K. Tsurugi, T. Yutsudo, Y. Takeda, T. Ogasawara, K. Igarashi.
reported Stx1 treatment increased activation ER                1988. Site action Vero toxin (VT2) Escherichia coli O157:H7 stress sensors IRE1, PERK, ATF6 myelogenous                     Shiga toxin eukaryotic ribosomes. RNA N-glycosidase activity                                                                            toxins. Eur. J. Biochem. 171:45â€“50.
leukemia cell line THP-1 (19). HMBEC, studies               7. Ergonul, ,  K. Hughes, D. E. Kohan. 2003. Induction apoptosis needed determine pathways activate                 human brain microvascular endothelial cells Shiga toxin 1. J. Infect. Dis.
CHOP promoter.                                                             187:154â€“158.
                                                                        8. Erwert, R. D., R. K. Winn, J. M. Harlan, D. D. Bannerman. 2002.
   experiments address possible role                  Shiga-like toxin inhibition FLICE-like inhibitory protein expression sen-
independent p38 mitogen-activated protein kinase pathway                   sitizes endothelial cells bacterial lipopolysaccharide-induced apoptosis.
                                                                           J. Biol. Chem. 277:40567â€“40574. Stx2-induced ribotoxic stress response,         9. Fujii, J., Y. Kinoshita, T. Kita,  Higure, T. Takeda, N. Tanaka, S.
pathway known activated Stx2 eukaryotic cells               Yoshida. 1996. Magnetic resonance imaging histopathological study (39). investigated connection CHOP                 brain lesions rabbits given intravenous verotoxin 2. Infect. Immun. 64:
                                                                           5053â€“5060.
apoptosis, thought caused proteins              10. Fujii, J., T. Kita, S. Yoshida, T. Takeda, H. Kobayashi, N. Tanaka, K.
stream CHOP. Following siRNA knockdown CHOP,                       Ohsato, Y. Mizuguchi. 1994. Direct evidence neuron impairment                                                                            oral infection verotoxin-producing Escherichia coli O157:Hâ«º mito-
concomitant decrease cleaved caspase-3 observed. Fur-               mycin-treated mice. Infect. Immun. 62:3447â€“3453.
ther studies needed determine CHOP leads             11. Fujii, J., T. Matsui, D. P. Heatherly, K. H. Schlegel, P.  Lobo, T. Yutsudo,
                                                                           G. M. Ciraolo, R. E. Morris, T. Obrig. 2003. Rapid apoptosis induced activation caspase-3. presence Stx2, HBMEC ex-                Shiga toxin HeLa cells. Infect. Immun. 71:2724â€“2735.
pression antiapoptotic protein c-FLIPL decreased 6 h,            12. Fukushima, H., T. Hashizume, Y. Morita, J. Tanaka, K. Azuma, Y. Mizu-
followed cleavage caspase-8 (Fig. 4C). c-FLIPL inhibits              moto, M. Kaneno, M. Matsuura, K. Konma, T. Kitani. 1999. Clinical
                                                                           experiences Sakai City Hospital massive outbreak entero-
caspase-8 activity, decrease c-FLIPL enhances                 hemorrhagic Escherichia coli O157 infections Sakai City, 1996. Pediatr.
activation caspase-8 death-inducing signaling com-               Int. 41:213â€“217.
                                                                       13. Heibein, J. , M. Barry, B. Motyka, R. C. Bleackley. 1999. Granzyme
plex. Initiation caspase-8 activity directly induced        B-induced loss mitochondrial inner membrane potential (Delta Psi m)
Stx inhibition protein synthesis, shown decrease           cytochrome c release caspase independent. J. Immunol. 163:4683â€“
                                                                           4693.
caspase-8 inhibitor c-FLIPL. Activated caspase-8 cleaves          14. Inward, C. D., J. Williams,  Chant, J. Crocker, D. V. Milford, P. E. Rose,
length Bid, truncated Bid known cause mitochon-              C. M. Taylor. 1995. Verocytotoxin-1 induces apoptosis Vero cells.
drial membrane rupture (48). result Bid activation,                J. Infect. 30:213â€“218.
                                                                       15. Jones, N. L.,  Islur, R. Haq, M. Mascarenhas, M.  Karmali, M. H.
release cytochrome c mitochondria cytoplasm                 Perdue, B. W. Zanke, P. M. Sherman. 2000. Escherichia coli Shiga toxins detected 12 h followed caspase-9                 induce apoptosis epithelial cells regulated Bcl-2 family.
                                                                            J. Physiol. Gastrointest. Liver Physiol. 278:G811â€“G819.
cleavage. observed activation additional caspases          16. Karpman, D.,  Hakansson, M. T. Perez, C. Isaksson, E. Carlemalm,  HBMEC response Stx2, data allow                 Caprioli, C. Svanborg. 1998. Apoptosis renal cortical cells                                                                            hemolytic-uremic syndrome: vivo vitro studies. Infect. Immun.
assign temporal order activation apoptosis factors.          66:636â€“644.  exogenous purified caspase-6, added HB-               17. Kiyokawa, N., T. Taguchi, T. Mori, H. Uchida, N. Sato, T. Takeda, J.
MEC lysate, able activate caspase-8 (Fig. 5), suggesting            Fujimoto. 1998. Induction apoptosis normal human renal tubular epi-
                                                                           thelial cells Escherichia coli Shiga toxins 1 2. J. Infect. Dis. 178:178â€“ occur cells.                                   184.
   summary, report E. coli Stx induces CHOP,          18. Kodama, T., K. Nagayama, K. Yamada, Y. Ohba, Y. Akeda, T. Honda.
                                                                           1999. Induction apoptosis human renal proximal tubular epithelial cells
interacts apoptotic cascade mediating activation            Escherichia coli verocytotoxin 1 vitro. Med. Microbiol. Immunol. 188:
caspase-3 HBMEC.                                                        73â€“78.
 VOL. 76, 2008                                                                                Stx2 CAUSES APOPTOSIS HBMEC CHOP                                 3689

19. Lee, S. Y., M. S. Lee, R. P. Cherla, V. L. Tesh. 2008. Shiga toxin 1 induces         Takeda. 1993. Characterization non-toxic mutant toxins Vero toxin 1
    apoptosis endoplasmic reticulum stress response human                     constructed replacing amino acids subunit. Microb.
    monocytic cells. Cell. Microbiol. 10:770â€“780.                                            Pathog. 15:169â€“176.
20. Li, P., D. Nijhawan,  Budihardjo, S. M. Srinivasula, M. Ahmad, E. S.             35.   Oyadomari, S., M. Mori. 2004. Roles CHOP/GADD153 endoplas-
    Alnemri, X. Wang. 1997. Cytochrome c dATP-depen